Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Ray, Monika ^a   Zhang, Weixiong ^a,b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; BRAIN; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY;

EID: 77957296042     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-136     Document Type: Article

References (63)

1. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics 2008, 33(2):240-256. 10.1152/physiolgenomics.00242.2007, 2826117, 18270320.
2. Valla J, Berndt JD, Gonzalez-Lima F. Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration. Journal of Neuroscience 2001, 21(13):4923-4930.
3. Vogt BA, Crino PB, Vogt LJ. Reorganization of Cingulate Cortex in Alzheimer's Disease: Neuron Loss, Neuritic Plaques, and Muscarinic Receptor Binding. Cereb Cortex 1992, 2(6):526-535. 10.1093/cercor/2.6.526, 1477528.
4. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-Specific Neurotrophin Imbalances in Alzheimer Disease. Archives of neurology 2000, 57(6):846-851. 10.1001/archneur.57.6.846, 10867782.
5. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 1998, 53:127-140.
6. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P. Coexpression Analysis of Human Genes Across Many Microarray Data Sets. Genome Research 2004, 14(6):1085-1094. 10.1101/gr.1910904, 419787, 15173114.
7. Elo LL, Jarvenpaa H, Oresic M, Lahesmaa R, Aittokallio T. Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process. Bioinformatics 2007, 23(16):2096-2103. 10.1093/bioinformatics/btm309, 17553854.
8. Oldham MC, Horvath S, Geschwind DH. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci USA 2006, 103(47):17973-17978. 10.1073/pnas.0605938103, 1693857, 17101986.
9. Stuart JM, Segal E, Koller D, Kim SK. A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules. Science 2003, 302(5643):249-255. 10.1126/science.1087447, 12934013.
10. Carlson MR, Zhang B, Fang Z, Mischel PS, Horvath S, Nelson SF. Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks. BMC Genomics 2006, 7:40. 10.1186/1471-2164-7-40, 1413526, 16515682.
11. Luscombe NM, Babu MM, Yu H, Snyder M, Teichmann SA, Gerstein M. Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 2004, 431:308-312. 10.1038/nature02782, 15372033.
12. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 1991, 82:239-259. 10.1007/BF00308809, 1759558.
13. Thal DR, Rub U, Orantes M, Braak H. Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58(12):1791-1800.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
15. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionising radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
16. Irizarry RA, Wu Z, Jaffee HA. Comparison of Affymetrix GeneChip expression measures. Bioinformatics 2006, 22(7):789-794. 10.1093/bioinformatics/btk046, 16410320.
17. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007, 356:319-350.
18. Ruan J, Zhang W. Identification and evaluation of functional modules in gene co-expression networks. Proc of RECOMB Satellite Conferences on Systems Biology and Computational Proteomics, San Diego, CA 2006, 57-76.
19. Ruan J, Dean AK, Zhang W. A general co-expression network-based approach to gene expression analysis: comparison and applications. BMC systems biology 2010, 4:8. 10.1186/1752-0509-4-8, 2829495, 20122284.
20. Leclerc RD. Survival of the sparsest: robust gene networks are parsimonious. Molecular systems biology 2008, 4:213. 10.1038/msb.2008.52, 2538912, 18682703.
21. Ray M, Ruan J, Zhang W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biology 2008, 9(10):R148. 10.1186/gb-2008-9-10-r148, 2760875, 18842138.
22. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical Organization of Modularity in Metabolic Networks. Science 2002, 297(5586):1551-1555. 10.1126/science.1073374, 12202830.
23. Zhang B, Horvath S. A General Framework for Weighted Gene Co-Expression Network Analysis. Statistical Applications in Genetics and Molecular Biology 2005, 4(1). 10.2202/1544-6115.1128, 16646834.
24. Chen R, Morgan AA, Dudley J, Deshpande T, Li L, Kodama K, Chaing AP, Butte AJ. FitSNPs: Highly differentially expressed genes are more likely to have variants associated with disease. Genome Biology 2008, 9(12):R170. 10.1186/gb-2008-9-12-r170, 2646274, 19061490.
25. Schwerin M, Czernek-Schafer D, Goldammer T, Kata SR, Womack JE, Pareek R, Pareek C, Walawski K, Brunner RM. Application of disease-associated differentially expressed genes: Mining for functional candidate genes for mastitis resistance in cattle. Genet Sel Evol 2003, 35(1):S19-34. 10.1186/1297-9686-35-S1-S19, 12927078.
26. Fang M, Wee SA, Ronski K, Fan H, Tao S, Lin Q. Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases. Genomic Medicine 2007, 1(1-2):75-85. 10.1007/s11568-007-9010-9, 2276883, 18923931.
27. Troyanskaya OG, Garber ME, Brown PO, Botstein D, Altman RB. Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics 2002, 18(11).
28. Fujarewicz K, Wiench M. Selecting differentially expressed genes for colon tumor classification. Int J Appl Math Comput Sci 2003, 13(3):327-335.
29. Dudoit S, Fridlyand J. Classification in microarray experiments. Statistical Analysis of Gene Expression Data 2003, 93-158. Speed T.
30. Dettling M, Buhlmann P. Finding predictive gene groups from microarray data. J Multivariate Anal 2004, 90:106-131.
31. Soukup M, Cho H, Lee J. Robust classification modeling on microarray data using misclassification penalized posterior. Bioinformatics 2005, 21(1):i423-i430. 10.1093/bioinformatics/bti1020, 15961487.
32. Francioso F, Carinci F, Tosi L, Scapoli L, Pezzetti F, Passerella E, Evangelisti R, Pastore A, Pelucchi S, Piattelli A, Rubini C, Fioroni M, Carinci P, Volinia S. Identification of differentially expressed genes in human salivary gland tumors by DNA microarrays. Mol Cancer Ther 2002, 1(7):533-538.
33. Chua CE, Tang BL. Syntaxin 16 is enriched in neuronal dendrites and may have a role in neurite outgrowth. Mol Membr Biol 2008, 25(1):35-45. 10.1080/09687680701504649, 17852734.
34. Cai L, Makhov AM, Bear JE. F-actin binding is essential for coronin 1B function in vivo. J Cell Sci 2007, 120(10):1779-1790. 10.1242/jcs.007641, 17456547.
35. Odell AF, Van Helden DF, Scott JL. The spectrin cytoskeleton influences the surface expression and activation of human transient receptor potential channel 4 channels. J Biol Chem 2008, 283(7):4395-4407. 10.1074/jbc.M709729200, 18048348.
36. Maul RS, Song Y, Amann KJ, Gerbin SC, Pollard TD, Chang DD. EPLIN regulates actin dynamics by cross-linking and stabilizing filaments. J Cell Biol 2003, 160(3):399-407. 10.1083/jcb.200212057, 2172667, 12566430.
37. Inoue E, Mochida S, Takagi H, Higa S, Deguchi-Tawarada M, Takao-Rikitsu E, Inoue M, Yao I, Takeuchi K, Kitajima I, Setou M, Ohtsuka T, Takai Y. SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release. Neuron 2006, 50(2):261-275. 10.1016/j.neuron.2006.03.018, 16630837.
38. Luo C, Lu X, Stubbs L, Kim J. Rapid evolution of a recently retroposed transcription factor YY2 in mammalian genomes. Genomics 2006, 87(3):348-355. 10.1016/j.ygeno.2005.11.001, 16377127.
39. Yao YL, Dupont BR, Ghosh S, Fang Y, Leach RJ, Seto E. Cloning, chromosomal localisation and promoter analysis of the human transcription factor YY1. Nucleic Acids Res 1998, 26(16):3776-3783. 10.1093/nar/26.16.3776, 147783, 9685495.
40. Nowak K, Lange-Dohna C, Zeitschel U, Gunther A, Luscher B, Robitzki A, Perez-Polo R, Rossner S. The transcription factor Yin Yang 1 is an activator of BACE1 expression. Journal of neurochemistry 2006, 96(6):1696-1707. 10.1111/j.1471-4159.2006.03692.x, 16539685.
41. Zacchetti D, Chieregatti E, Bettegazzi B, Mihailovich M, Sousa VL, Grohovaz F, Meldolesi J. BACE1 expression and activity: relevance in Alzheimer's disease. Neurodegener Dis 2007, 4(2-3):117-126. 10.1159/000101836, 17596706.
42. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of toll-like receptor signalling in A-beta uptake and clearance. Brain 2006, 129(11):3006-3019. 10.1093/brain/awl249, 2445613, 16984903.
43. Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation 2008, 5:23. 10.1186/1742-2094-5-23, 2430555, 18510752.
44. Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP. Molecular genetics of the caveolin gene family implications for human cancers, diabetes, Alzheimer's disease, and muscular dystrophy. Am J Hum Genet 1998, 63(6):1578-1587. 10.1086/302172, 1377628, 9837809.
45. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993, 33(6):403-408. 10.1159/000116984, 8307060.
46. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease. Science 2005, 307(5713):1282-1288. 10.1126/science.1105681, 15731448.
47. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes, Brain and Behaviour 2008, 7(s1):43-56.
48. Smith KD, Kallhoff V, Zheng H, Pautler RG. In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 2007, 35(4):1401-1408. 10.1016/j.neuroimage.2007.01.046, 2063432, 17369054.
49. Lukiw WJ, Bazan NG. Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem Res 2000, 25(9-10):1173-1184. 10.1023/A:1007627725251, 11059791.
50. Lemere CA. A beneficial role for IL-1beta in Alzheimer disease?. Journal of Clinical Investigation 2007, 117(6):1483-1485. 10.1172/JCI32356, 1878536, 17549252.
51. Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI. Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease. Journal of Neuroscience 2004, 24(36):7895-7902. 10.1523/JNEUROSCI.1988-04.2004, 15356202.
52. Albrecht S, Bourdeau M, Bennett D, Mufson E, Bhattacharjee M, LeBlanc AC. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 2007, 170(4):1200-1209. 10.2353/ajpath.2007.060974, 1829454, 17392160.
53. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 2004, 165(2):523-531. 1618555, 15277226.
54. Richter B, Duckett CS. The IAP Proteins: Caspase Inhibitors and Beyond. Science signalling 2000, 44:PE1.
55. Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K, Roebroek AJ, Schwake M, D'Hooge R, Bach P, Kalinke U, Moechars D, Alzheimer C, Reiss K, Saftig P, De Strooper B. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem 2005, 280(35):30797-30806. 10.1074/jbc.M505249200, 15987683.
56. Farzan M, Schnitzler C, Vasilieva N, Leung D, Choe H. BACE2, a beta-secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Proc Natl Acad Sci USA 2000, 97(17):9712-9717. 10.1073/pnas.160115697, 16930, 10931940.
57. Chen L, Na R, Gu M, Richardson A, Ran Q. Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J Neurochem 2008, 107(1):197-207. 10.1111/j.1471-4159.2008.05603.x, 2716044, 18680556.
58. Stockley JH, Ravid R, O'Neill C. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain. FEBS Letters 2006, 580(28-29):6550-6560. 10.1016/j.febslet.2006.10.076, 17113083.
59. McGeer EG, McGeer PL, Akiyama H, Harrop R. Cortical glutaminase, beta-glucuronidase and glucose utilization in Alzheimer's disease. Canadian Journal of Neurological Sciences 1989, 16(suppl 4).
60. Kovacs GG, Laszlo L, Kovacs J, Jensen PH, Lindersson E, Botond G, Molnar T, Perczel A, Hudecz F, Mezo G, Erdei A, Tirian L, Lehotzky A, Gelpi E, Budka H, Ovadi J. Natively unfolded tubulin poly-merization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiology of Disease 2004, 17(2):155-162. 10.1016/j.nbd.2004.06.006, 15474353.
61. Nguyen TV, Galvan V, Huang W, Banwait S, Tang H, Zhang J, Bredesen DE. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J Neurochem 2008, 104(4):1065-1080. 10.1111/j.1471-4159.2007.05031.x, 2553705, 17986220.
62. Zhao L, Ma QL, Calon F, Harris-White ME, Yang F, Lim GP, Morihara T, Ubeda OJ, Ambegaokar S, Hansen JE, Weisbart RH, Teter B, Frautschy SA, Cole GM. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nature neuroscience 2006, 9(2):234-242. 10.1038/nn1630, 16415866.
63. Thangavel R, Sahu SK, Van Hoesen GW, Zaheer A. Modular and laminar pathology of Brodmann's area 37 in Alzheimer's disease. Neuroanatomy 2008, 152(1):50-55.